Naloxone Dosing After Opioid Overdose in the Era of Illicitly Manufactured Fentanyl
- PMID: 31471760
- PMCID: PMC6942078
- DOI: 10.1007/s13181-019-00735-w
Naloxone Dosing After Opioid Overdose in the Era of Illicitly Manufactured Fentanyl
Abstract
Introduction: Illicitly manufactured fentanyl (IMF) is responsible for a growing number of deaths. Some case series have suggested that IMF overdoses require significantly higher naloxone doses than heroin overdoses. Our objective was to determine if the naloxone dose required to treat an opioid overdose is associated with the finding of fentanyl, opiates, or both on urine drug screen (UDS).
Methods: A retrospective chart review was conducted at a single emergency department and its affiliated emergency medical services (EMS) agency. The charts of all patients who received naloxone through this EMS from 1/1/2017 to 6/15/2018 were reviewed. The study included patients diagnosed with a non-suicidal opioid overdose whose UDS was positive for opiates, fentanyl, or both. Data collected included demographics, vital signs, initial GCS, EMS and ED naloxone administrations, response to treatment, laboratory findings, and ED disposition. The fentanyl-only and fentanyl + opiate groups were compared to the opiate-only group using the stratified (by ED provider) variant of the Mann-Whitney U test.
Results: Eight hundred and thirty-seven charts were reviewed, and 121 subjects were included in the final analysis. The median age of included subjects was 38 years and 75% were male. In the naloxone dose analysis, neither the fentanyl-only (median 0.8 mg, IQR 0.4-1.6; p = 0.68) nor the fentanyl + opiate (median 0.8 mg, IQR 0.4-1.2; p = 0.56) groups differed from the opiate-only group (median 0.58 mg, IQR 0.4-1.6).
Conclusion: Our findings refute the notion that high potency synthetic opioids like illicitly manufactured fentanyl require increased doses of naloxone to successfully treat an overdose. There were no significant differences in the dose of naloxone required to treat opioid overdose patients with UDS evidence of exposure to fentanyl, opiates, or both. Further evaluation of naloxone stocking and dosing protocols is needed.
Keywords: Drug overdose; Emergency medical services; Fentanyl; Naloxone; Opiates.
Conflict of interest statement
None.
Figures
Similar articles
-
A Novel Oral Fluid Assay (LC-QTOF-MS) for the Detection of Fentanyl and Clandestine Opioids in Oral Fluid After Reported Heroin Overdose.J Med Toxicol. 2017 Dec;13(4):287-292. doi: 10.1007/s13181-017-0632-6. Epub 2017 Oct 2. J Med Toxicol. 2017. PMID: 28971325 Free PMC article.
-
The role of take-home naloxone in the epidemic of opioid overdose involving illicitly manufactured fentanyl and its analogs.Expert Opin Drug Saf. 2019 Jun;18(6):465-475. doi: 10.1080/14740338.2019.1613372. Epub 2019 May 16. Expert Opin Drug Saf. 2019. PMID: 31033357 Review.
-
Amount of naloxone used to reverse opioid overdoses outside of medical practice in a city with increasing illicitly manufactured fentanyl in illicit drug supply.Subst Abus. 2019;40(1):52-55. doi: 10.1080/08897077.2018.1449053. Epub 2018 Jun 25. Subst Abus. 2019. PMID: 29558283
-
Naloxone for heroin, prescription opioid, and illicitly made fentanyl overdoses: Challenges and innovations responding to a dynamic epidemic.Int J Drug Policy. 2017 Aug;46:172-179. doi: 10.1016/j.drugpo.2017.06.005. Epub 2017 Jul 4. Int J Drug Policy. 2017. PMID: 28687187 Free PMC article.
-
The need for multiple naloxone administrations for opioid overdose reversals: A review of the literature.Subst Abus. 2022;43(1):774-784. doi: 10.1080/08897077.2021.2010252. Subst Abus. 2022. PMID: 35112993 Review.
Cited by
-
Targeting α1- and α2-adrenergic receptors as a countermeasure for fentanyl-induced locomotor and ventilatory depression.Environ Toxicol Pharmacol. 2024 Sep;110:104527. doi: 10.1016/j.etap.2024.104527. Epub 2024 Aug 4. Environ Toxicol Pharmacol. 2024. PMID: 39106924
-
Modeling of overdose and naloxone distribution in the setting of fentanyl compared to heroin.Drug Alcohol Depend. 2022 Jul 1;236:109478. doi: 10.1016/j.drugalcdep.2022.109478. Epub 2022 Apr 29. Drug Alcohol Depend. 2022. PMID: 35588609 Free PMC article.
-
High-dose naloxone formulations are not as essential as we thought.Harm Reduct J. 2024 May 13;21(1):93. doi: 10.1186/s12954-024-00994-z. Harm Reduct J. 2024. PMID: 38741224 Free PMC article. Review.
-
Intranasal Naloxone Repeat Dosing Strategies and Fentanyl Overdose: A Simulation-Based Randomized Clinical Trial.JAMA Netw Open. 2024 Jan 2;7(1):e2351839. doi: 10.1001/jamanetworkopen.2023.51839. JAMA Netw Open. 2024. PMID: 38261323 Free PMC article. Clinical Trial.
-
Long-Lasting Analgesia With Transdermal Fentanyl: A New Approach in Rat Neonatal Research.Front Pharmacol. 2022 Mar 17;13:798011. doi: 10.3389/fphar.2022.798011. eCollection 2022. Front Pharmacol. 2022. PMID: 35370716 Free PMC article.
References
-
- Ahmad F, Rossen L, Spencer M, Warner M, Sutton P. Provisional drug overdose death counts. National Center for Health Statistics; 2018.
-
- Kochanek K, Muprhy S, Xu J, Arias E. Mortality in the United States, 2016 National Center for Health Statistics; 2017.
-
- Peterson AB, Gladden RM, Delcher C, Spies E, Garcia-Williams A, Wang Y, Halpin J, Zibbell J, McCarty CL, DeFiore-Hyrmer J, DiOrio M, Goldberger BA. Increases in fentanyl-related overdose deaths—Florida and Ohio, 2013-2015. MMWR Morb Mortal Wkly Rep. 2016;65(33):844–849. doi: 10.15585/mmwr.mm6533a3. - DOI - PubMed
-
- CDC Health Alert Network. Increases in fentanyl drug confiscations and fentanyl-related overdose fatalities. 2015. https://emergency.cdc.gov/han/han00384.asp. Accessed 10 Apr 2019.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
